期刊文献+

Clinical study of preoperative fT4/fT3 quotient and thyroid function test in distinguishing benign from malignant thyroid nodules

下载PDF
导出
摘要 Objective:To analyze the clinical and pathological characteristics of thyroid nodules and to explore the related risk factors of malignant thyroid nodules.Methods: According to the criteria of inclusion and exclusion, a total of 283 patients with thyroid nodules during January 2015 and December 2017 were divided into benign group (benign nodule,n =172) and malignant group (malignant nodule,n = 111) based on postoperative histopathological results. The age, sex, serum thyroglobulin antibody (TgAb), thyroid peroxidase antibody (TPOAb), thyroid stimulating hormone (TSH), free thyroxine (fT4), free three iodine thyroxine (fT3) and fT4/ fT3 ratio were subjected to univariate analysis, and the risk factors of malignant thyroid nodule were screened by multivariate logistic regression analysis.Results:Univariate analysis showed that age, TgAb, fT4 (P < 0.05) and fT4/ fT3 quotient (P < 0.01) were significantly different between the two groups. The fT4/fT3 quotient is a risk factor of malignant nodules. Multivariate logistic regression analysis indicated that the risk factors of malignant thyroid nodule were age (0R: 0.934,95% CI:0.911-0.957), TgAb(0R: 2.069,95% CI: 1.008-4.247) and fT4 (0R: 1.206,95% CI: 1.038-1.401).Conclusion: The fT4/fT3 quotient has important diagnostic value in differentiating benign and malignant thyroid nodules. When fT4 / fT3 > 3, it increases the risk of malignancy. The age, TgAb and fT4 are independent risk factors for malignant thyroid nodule, which is of great value in distinguishing benign from malignant thyroid nodules.
出处 《Journal of Hainan Medical University》 2018年第20期52-56,共5页 海南医学院学报(英文版)
基金 National Natural Science Foundation of China.Projects No:81302577.
  • 相关文献

参考文献4

二级参考文献64

  • 1刘洪枫,唐伟松,杨志英.甲状腺钙化性病灶与甲状腺癌[J].中国医学科学院学报,2003,25(5):626-629. 被引量:147
  • 2Dean D S, Gharib H. Epidemiology of thyroid nodules [J]. Best Pract Res Clin Endocrinol Metab, 2008,22 (6) :901-911.
  • 3American Thyroid Association (ATA) Guidelines Task- force on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper D S, Doherty G M, et al. Revised A- merican Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer[ J]. Thyroid, 2009,19 ( 11 ) : 1167-1214.
  • 4Gharib H, Papini E, Paschke R, et al. American Asso- ciation of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medi- cal guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations [ J ]. Endocrinol Invest, 2010, 33 ( 5 Suppl) :51-56.
  • 5Ayturk S, Gursoy A, Kut A, et al. Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate io- dine-deficient area [ J ]. Eur J Endocrinol, 2009, 161 (4) :599-605.
  • 6Rezzonico J, Rezzonico M, Pusiol E, et al. Introducing the thyroid gland as another victim of the insulin resist- ance syndrome[ J]. Thyroid, 2008,18 ( 4 ) :461-464.
  • 7Anil C, Akkurt A, Ayturk S, et al. Impaired glucose metabolism is a risk factor for increased thyroid volume- and nodule prevalence in a mild-to-moderate iodine deft- cient area [ J ]. Metabolism, 2013,62 ( 7 ) : 970-975.
  • 8Leenhardt L. Management of thyroid nodule [ J ]. J Radiol, 2009, 90(3 Pt 2) :354-361.
  • 9Rago T, Fiore E, Scutari M, et al. Male sex, single nod- ularity, and young age are associated with the risk of finding a papillary thyroid cancer on fine-needle aspira- tion cytology in a large series of patients with nodular thy- roid disease[J]. Eur J Endocrinol, 2010,162 (4) :763- 770.
  • 10Nyenwe E A, Jerkins T W, Umpierrez G E, et al. Man- agement of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes [ J ]. Metabo- lism, 2011,60(1) :1-23.

共引文献128

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部